Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NP closed at $27.19 on Tuesday, down nearly 2% on the week and 18% over the past month, yet its next earnings print is just 14 days away.
The most striking signal this week is not in the short book. It is in Wikipedia and ORTEX page-view data, which show retail attention running at nearly five standard deviations above NP's own 90-day history. That is an unusually high reading for a small-cap specialty insurer with concentrated ownership and thin options activity. Attention alone is not a revenue indicator, but a z-score of 4.9 in the fortnight before a print is worth noting.
The lending market is a non-story. Short interest is just under 2% of the free float, roughly 1.8 million shares, and availability is extraordinarily loose at over 4,200%, meaning there are more than 40 shares available to borrow for every one already lent out. Borrowing costs have drifted back to under 0.5% annualised after touching 0.84% in early September. The borrow has been easing all month: SI fell 22% over 30 days even as it ticked up 1.5% this week. That weekly uptick is trivial against the broader trend. Nothing in the lending market points to meaningful short conviction. The options picture is marginally more defensive: the put/call ratio reached a 52-week high of 0.24 on Tuesday, about one standard deviation above its 20-day average of 0.11. That is elevated by NP's own standards, though the absolute level is far from alarming, and much of the activity likely reflects thin liquidity rather than organised hedging.
The Street is in a mild retreat ahead of the October 21 print. Mizuho cut its price target from $32 to $31 this morning, keeping a Neutral rating, a modest trim that lands while the stock trades almost 15% below that level. The broader analyst cluster remains split: Morgan Stanley upgraded to Overweight in August, lifting its target to $36, while BMO downgraded to Market Perform in July. Wells Fargo and Piper Sandler both carry Overweight ratings, with the latter's $39 target the highest on the Street. The consensus mean is $34.38 against a $27.19 close, implying 26% return potential on paper, though the 18% monthly decline has widened that gap quickly. The bull case rests on a 92% retention rate, improved revenue guidance of $193 million for 2026, and NP's positioning as a data-driven MGA that consistently outperforms the National Flood Insurance Program on loss ratios. Bears counter that more than 96% of policy sales run through third-party agents, agent productivity is a live risk, and property-value stress could squeeze premiums and inflate claims simultaneously. The PE multiple has compressed sharply, falling more than 10 points over 30 days to 42x, reflecting the stock's decline rather than any earnings revision.
Ownership is heavily concentrated at the top. CEO Trevor Burgess holds 32% of shares. James Albert controls another 10%. FTV VII, L.P. and BSIV Hold 101 together account for a further 32%, though both reduced their stakes materially in their August 13G/A amendments, FTV from 23.6% to 17.2% and BSIV from 20.7% to 15.0%. No 13D activist appears on the register. T. Rowe Price lifted its position to just above 6% in an August filing, a constructive move from a long-only manager. BlackRock built a new position of nearly 2.4 million shares as recently as September 30. These institutional inflows offer some counterweight to the insider selling.
The insider flow deserves a careful read. The 90-day net is minus 3.8 million shares, worth roughly $126 million. Most of the October selling, two tranches from President and Chief Risk Officer Matthew Duffy totalling around $2.2 million, was executed under a pre-arranged 10b5-1 plan, which sharply reduces the informational content. The September 30 activity across Burgess, Duffy, CFO James Steiner, and director Jonathan Carlon was a mix of compensation grants and associated tax-withholding sales, standard mechanics, not discretionary conviction. Read in isolation, the net number looks alarming; in context, most of it is plan-driven or compensation-related.
The last earnings print, in late July, saw the stock fall 5% on the day before recovering almost 1% over the following five days. The prior quarter showed a smaller 1.5% day-one drop followed by a 16% five-day gain. The pattern is one of initial disappointment giving way to a more constructive reassessment, though with only two historical reactions in the data, any read is tentative. What to watch on October 21 is whether the retention rate and revenue guidance hold, and whether agent-channel productivity shows any deterioration, the single metric bears cite most often as the pivotal risk.
See the live data behind this article on ORTEX.
Open NP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
